• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Use of Device Problem (1670)
Patient Problems Nausea (1970); Tingling (2171); No Code Available (3191)
Event Date 12/12/2019
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the calcium gluconate perfusion and 0.9% saline that were provided to the patient.Since this event is associated with the kit, this mdr will be against the kit.No product was returned for investigation.Kit lot h135 was reviewed.There were no non-conformances related to the complaint.This lot met all release requirements.A review of kit lot h135 shows no trends.The root cause for this complaint has been determined to be use error as the customer has acknowledged that they made the mistake of connecting the saline and anticoagulant spikes to the wrong iv bags during kit set up.The saline spike was connected to the anticoagulant iv bag which allowed the patient to receive more anticoagulant than normal.Both the anticoagulant (a/c) and saline line are color coded for easy identification.The a/c line and associated spike are colored coded (green or orange), while the saline line and spike are clear.Section 3-32 of the operator's manual states "the a/c source line connects the anticoagulant solution bag and the pump tubing organizer.It has a spike chamber and is identified with a (green or orange) stripe on the tubing." in addition, in section 4-23 of the operator's manual entitled preparing and hanging saline and anticoagulant solutions it states, "spike the anticoagulant solution with the spike attached to the (green or orange striped) line.Hang the anticoagulant bag on the lower right side of the instrument (as you face it) using the back hook.Spike a 500 ml bag of 0.9% normal saline with the spike attached to the clear line.Hang the saline bag on the lower right side of the instrument (as you face it) using the front hook." figure 4-26 in the operator's manual provides a color photo showing the proper placement and spiking of both the saline and a/c iv bags.A technical bulletin, technical bulletin #22: anticoagulant (a/c) spike and tubing color update, was also sent to all global customers in multiple languages in 2015 stating the anticoagulant spike and tubing in the therakos cellex system procedural kit may have either a white spike with green striped tubing or an orange spike with orange striped tubing.The a/c spike and tubing color change to all orange will be phased in during 2016.Trends were reviewed for complaint categories, bags/lines swapped: anticoagulant and saline lines, hypocalcemia, nausea, and paresthesia.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: no code available: hypocalcemia, nausea, and tingling.(b)(4).
 
Event Description
The customer reported by email that an extracorporeal photopheresis (ecp) patient experienced hypocalcemia, nausea, and paresthesia during a treatment procedure.The customer stated that at the very beginning of the patient's ecp treatment procedure, the patient exhibited signs of "major hypocalcemia".The customer reported that the patient complained of both nausea and paresthesia of the face.The customer reported that they instantly discovered that the kit's lines for both the saline 0.9% and anticoagulant (acd-a) iv bags had been accidentally inverted during set-up.The customer stated that the patient's ecp treatment procedure was immediately paused and the patient was administered a calcium gluconate perfusion along with 0.9% saline.The customer reported that the patient's clinical signs disappeared rapidly and the patient's ecg was normal.The customer stated that the patient's ecp treatment procedure was then aborted with no blood or treated cells returned to the patient.The customer reported that the patient's ecp treatment procedure was postponed till the next week.The customer stated that the patient has been treated several times since this incident without any issues and the patient is currently in good condition.The customer reported that there were no errors in regards to the line layout of the kit, instead they just made a "mistake" during the installation of the kit.The customer stated that they will now mark the kit's anticoagulant tubing with a fluorescent label and will verify the installation and setup of the kit with two different nurses.No product was returned for investigation as the kit had already been discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin, D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key9656812
MDR Text Key190810944
Report Number2523595-2020-00020
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 02/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/01/2021
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCLXECP
Device Lot NumberH135
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/03/2020
Initial Date FDA Received02/01/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/09/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age32 YR
Patient Weight54
-
-